journal article·2017-01-02Open access

Magnetic nanoparticles in cancer diagnosis and treatment: a review

Sonia Fathi Karkan, Majid Mohammadhosseini, Yunes Panahi, Morteza Milani, Nosratollah Zarghami, Abolfazl Akbarzadeh, Elham Abasi, Arastoo Hosseini, Soodabeh Davaran

Abstract

Diagnosis and treatment of lung cancer have been characterized with a variety of challenges. However, with the advancement in magnetic nanoparticle (MNP) technology, many challenges in the diagnosis and treatment of lung cancer are on the decline. The MNPs have led to many break-through in cancer therapy. This paper seeks to establish the role of MNPs in diagnosis and treatment of lung cancer. It proposes that the existing challenges in the diagnosis and treatment of lung cancer can be addressed through application of MNPs in the process.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Biosensors and Analytical Detection

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran;

Department of Medical Nanotechnology Faculty of Advanced Medical Science, Medical University of Tabriz, Tabriz, Iran;

Department of Chemistry, Shahrood Branch, Islamic Azad University, Shahrood, Iran;

Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran;

Department of Medical Nanotechnology Faculty of Advanced Medical Science, Iran University of Medical Sicences, Tehran, Iran

References (56)

Show source-provided references
1. 10.4172/2155-983X.100011510.4172/2155-983X.1000115 ↗
2. 10.1186/1556-276X-7-14410.1186/1556-276X-7-144 ↗
3. 10.1186/1477-3155-10-4610.1186/1477-3155-10-46 ↗
4. 10.3109/21691401.2015.102963310.3109/21691401.2015.1029633 ↗
5. 10.1016/j.addr.2012.09.00410.1016/j.addr.2012.09.004 ↗
6. 10.1007/s11095-012-0710-z10.1007/s11095-012-0710-z ↗
7. 10.1007/s11095-012-0710-z10.1007/s11095-012-0710-z ↗
8. 10.3109/21691401.2015.110100010.3109/21691401.2015.1101000 ↗
9. 10.1155/2013/86395110.1155/2013/863951 ↗
10. Baviskar DT · Die Pharmazie Int J Pharm Sci. · 2012 · 67 · 701
11. 10.1371/journal.pone.005733210.1371/journal.pone.0057332 ↗
12. Chung JH, Kim YK, Kim KH, Kwon TY, Vaezmomeni SZ, Samiei M, et al. 2016. Synthesis, characterization, biocompatibility of hydroxyapatite-natural polymers nanocomposites for dentistry applications. Artif Cells Nanomed Biotechnol. 44:277–284.10.3109/21691401.2014.944644 ↗
13. 10.1039/c2cs15337h10.1039/c2cs15337h ↗
14. 10.3109/21691401.2015.103190510.3109/21691401.2015.1031905 ↗
15. 10.1088/0957-4484/24/37/37510110.1088/0957-4484/24/37/375101 ↗
16. 10.1088/1367-2630/14/1/01302510.1088/1367-2630/14/1/013025 ↗
17. 10.1515/ntrev-2013-001110.1515/ntrev-2013-0011 ↗
18. Eatemadi A, Daraee H, Zarghami N, Yar HM, Akbarzadeh A. 2016a. Nanofiber: synthesis and biomedical applications. Artif Cells Nanomed Biotechnol. 44:111–121.10.3109/21691401.2014.922568 ↗
19. 10.3109/21691401.2014.94464610.3109/21691401.2014.944646 ↗
20. 10.3109/21691401.2014.96882210.3109/21691401.2014.968822 ↗
21. 10.1109/LAWP.2010.204381010.1109/LAWP.2010.2043810 ↗
22. 10.1007/BF0324585610.1007/BF03245856 ↗
23. 10.3390/ma304241210.3390/ma3042412 ↗
24. 10.7150/thno.1154410.7150/thno.11544 ↗
25. 10.3109/21691401.2015.112961910.3109/21691401.2015.1129619 ↗
26. 10.1063/1.368808410.1063/1.3688084 ↗
27. 10.1007/s10948-012-1941-210.1007/s10948-012-1941-2 ↗
28. 10.1016/j.biomaterials.2004.10.01210.1016/j.biomaterials.2004.10.012 ↗
29. 10.1158/0008-5472.CAN-10-102210.1158/0008-5472.CAN-10-1022 ↗
30. 10.1186/1556-276X-8-6610.1186/1556-276X-8-66 ↗
31. 10.1161/HYPERTENSIONAHA.108.12141810.1161/HYPERTENSIONAHA.108.121418 ↗
32. 10.1093/abbs/gms03910.1093/abbs/gms039 ↗
33. 10.1016/S0169-409X(00)00122-810.1016/S0169-409X(00)00122-8 ↗
34. 10.1016/j.jmmm.2012.08.03410.1016/j.jmmm.2012.08.034 ↗
35. 10.1016/j.ijpharm.2015.07.05910.1016/j.ijpharm.2015.07.059 ↗
36. 10.1021/nn202108810.1021/nn2021088 ↗
37. 10.1007/s11060-010-0389-010.1007/s11060-010-0389-0 ↗
38. 10.1016/j.addr.2008.03.01410.1016/j.addr.2008.03.014 ↗
39. 10.1021/acs.molpharmaceut.5b0030410.1021/acs.molpharmaceut.5b00304 ↗
40. 10.1038/nnano.2009.20210.1038/nnano.2009.202 ↗
41. 10.3109/21691401.2014.95363210.3109/21691401.2014.953632 ↗
42. 10.3390/nano501006310.3390/nano5010063 ↗
43. 10.1007/s11064-014-1380-510.1007/s11064-014-1380-5 ↗
44. 10.3109/21691401.2015.103699910.3109/21691401.2015.1036999 ↗
45. 10.1016/j.jmmm.2012.02.07510.1016/j.jmmm.2012.02.075 ↗
46. 10.1016/j.biomaterials.2013.03.06110.1016/j.biomaterials.2013.03.061 ↗
47. 10.1080/0265673090280311810.1080/02656730902803118 ↗
48. 10.1021/js980084y10.1021/js980084y ↗
49. 10.1016/S0168-3659(00)00339-410.1016/S0168-3659(00)00339-4 ↗
50. 10.1186/2228-5326-3-4510.1186/2228-5326-3-45 ↗
51. 10.1016/j.addr.2008.03.01810.1016/j.addr.2008.03.018 ↗
52. 10.3109/21691401.2014.95510810.3109/21691401.2014.955108 ↗
53. 10.1088/0022-3727/36/13/20210.1088/0022-3727/36/13/202 ↗
54. 10.1016/S1567-2719(05)16005-310.1016/S1567-2719(05)16005-3 ↗
55. 10.3322/caac.2119910.3322/caac.21199 ↗
56. 10.4103/0973-1482.9516810.4103/0973-1482.95168 ↗